Ignite Creation Date:
2024-05-06 @ 6:10 PM
Last Modification Date:
2024-10-26 @ 2:42 PM
Study NCT ID:
NCT05565794
Status:
RECRUITING
Last Update Posted:
2023-08-28
First Post:
2022-09-28
Brief Title:
Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 FusionRearrangements
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-28
First Submit QC Date:
September 30 2022
Study First Post Date:
2022-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-24
Last Update Post Date:
2023-08-28
Last Update Post Date Type:
ACTUAL